Compare BNED & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNED | CGC |
|---|---|---|
| Founded | 1965 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.3M | 389.2M |
| IPO Year | 2015 | 2023 |
| Metric | BNED | CGC |
|---|---|---|
| Price | $13.56 | $0.69 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | 201.8K | ★ 2.3M |
| Earning Date | 09-08-2026 | 11-06-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 119.60 | 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,714,770,000.00 | $12,759,000.00 |
| Revenue This Year | $2.88 | $18.83 |
| Revenue Next Year | N/A | $7.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.50 | N/A |
| 52 Week Low | $5.90 | $0.65 |
| 52 Week High | $14.75 | $2.38 |
| Indicator | BNED | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 29.11 |
| Support Level | $11.55 | N/A |
| Resistance Level | $14.75 | $1.08 |
| Average True Range (ATR) | 0.44 | 0.05 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 84.08 | 17.70 |
Barnes & Noble Education Inc is contract operators of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also one of the textbook wholesalers and inventory management hardware and software providers The company operates physical and virtual bookstores that delivers essential educational content and general merchandise within a dynamic omnichannel retail environment. The Company currently operates as a single operating and reporting segment. The company's solutions are Academic Solutions, College Retail Solutions, College Insights, Wholesale & Store Technology Services.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.